Related references
Note: Only part of the references are listed.Trans-presentation of IL-6 by dendritic cells is required for the priming of pathogenic TH17 cells
Sylvia Heink et al.
NATURE IMMUNOLOGY (2017)
Effects of tocilizumab on neutrophil function and kinetics
Laurence S. C. Lok et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2017)
The importance of being pure neutrophils
Federica Calzetti et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Tocilizumab in systemic juvenile idiopathic arthritis in a real-world clinical setting: results from 1 year of postmarketing surveillance follow-up of 417 patients in Japan
Shumpei Yokota et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Adult human megakaryocyte-erythroid progenitors are in the CD34+CD38mid fraction
Chad Sanada et al.
BLOOD (2016)
Cytokine release syndrome with novel therapeutics for acute lymphoblastic leukemia
Noelle V. Frey et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2016)
IL-6 as a keystone cytokine in health and disease
Christopher A. Hunter et al.
NATURE IMMUNOLOGY (2015)
Whose Gene Is It Anyway? The Effect of Preparation Purity on Neutrophil Transcriptome Studies
Huw B. Thomas et al.
PLOS ONE (2015)
Tocilizumab-induced neutropenia in rheumatoid arthritis patients with previous history of neutropenia: case series and review of literature
O. Shovman et al.
IMMUNOLOGIC RESEARCH (2015)
Effectiveness and Safety of Tocilizumab: Postmarketing Surveillance of 7901 Patients with Rheumatoid Arthritis in Japan
Takao Koike et al.
JOURNAL OF RHEUMATOLOGY (2014)
Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1/2 trial
Glen A. Kennedy et al.
LANCET ONCOLOGY (2014)
The multifactorial role of neutrophils in rheumatoid arthritis
Helen L. Wright et al.
NATURE REVIEWS RHEUMATOLOGY (2014)
IL-6 biology: implications for clinical targeting in rheumatic disease
Leonard H. Calabrese et al.
NATURE REVIEWS RHEUMATOLOGY (2014)
Effects of IL-6 and IL-6 blockade on neutrophil function in vitro and in vivo
Helen L. Wright et al.
RHEUMATOLOGY (2014)
IL-6 trans-Signaling-Dependent Rapid Development of Cytotoxic CD8+ T Cell Function
Jan P. Boettcher et al.
CELL REPORTS (2014)
Depletion of Jak2V617F myeloproliferative neoplasm-propagating stem cells by interferon-α in a murine model of polycythemia vera
Ann Mullally et al.
BLOOD (2013)
Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial
Cem Gabay et al.
LANCET (2013)
HemaExplorer: a Web server for easy and fast visualization of gene expression in normal and malignant hematopoiesis
Frederik Otzen Bagger et al.
BLOOD (2012)
Essential role of IL-6 in protection against H1N1 influenza virus by promoting neutrophil survival in the lung
O. Dienz et al.
MUCOSAL IMMUNOLOGY (2012)
Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis
Fabrizio De Benedetti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling
Simon A. Jones et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Safety and efficacy profiles of tocilizumab monotherapy in Japanese patients with rheumatoid arthritis: meta-analysis of six initial trials and five long-term extensions
Norihiro Nishimoto et al.
MODERN RHEUMATOLOGY (2010)
IL6/slIL6R complex contributes to emergency granulopoietic responses in G-CSF- and GM-CSF-deficient mice
Francesca Walker et al.
BLOOD (2008)
Transgenic blockade of interleukin 6 transsignaling abrogates inflammation
Bjorn Rabe et al.
BLOOD (2008)
Apoptosis is a natural stimulus of IL6R shedding and contributes to the proinflammatory trans-signaling function of neutrophils
Athena Chalaris et al.
BLOOD (2007)
Differential expression of CD126 and CD130 mediates different STAT-3 phosphorylation in CD4+CD25- and CD25high regulatory t cells
HH Oberg et al.
INTERNATIONAL IMMUNOLOGY (2006)
Effect of pro-inflammatory cytokines on spontaneous apoptosis in leukocyte sub-sets within a whole blood culture
JP McNamee et al.
CYTOKINE (2005)
Principles of interleukin (IL)-6-type cytokine signalling and its regulation
PC Heinrich et al.
BIOCHEMICAL JOURNAL (2003)
IL-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation
SM Hurst et al.
IMMUNITY (2001)
Activation-induced inhibition of interleukin 6-mediated T cell survival and signal transducer and activator of transcription 1 signaling
TK Teague et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
